% | $
Quotes you view appear here for quick access.

Celgene Corporation Message Board

  • rob_cos rob_cos May 8, 2013 9:56 AM Flag

    EXTREMELY IMPORTANT Bernstein comment on current CELG management team - consistent with my post yesterday....

    Full Bernstein comment does not fit - see investor village CELG board for full report but this comment is of PARAMOUNT IMPORTANCE

    EXTREMELY IMPORTANT Bernstein comment on current CELG management team - consistent with my post yesterday......

    · Management transition now complete and new (ish) team finding their groove. In many ways we view these investor events as a Rorschach test of a management's strategy, confidence and command of their business. Leadership are subject to extended questioning at such events that is more open and spontaneous than the careful orchestration of quarterly conference calls and investor conference presentations. In this respect Celgene's management will have gained credibility with investors – there were no embarrassing gaffes, disappointments or differences of opinion or views; the company offered up many different executives, rather than just the usual carefully scripted "c-suite" leadership, and those executives echoed the enthusiasm and energy conveyed by those top executives. While the company's CEO and CFO answered questions at the end of the event, the vast majority of the content, and the commentary, came from division or functional unit managers. This will give investors confidence that the company's leadership bench is deep and talented, that their industry knowledge and expertise is broad, and that the technical and commercial judgments are being made on the best expertise and information available in the industry. At times in the past Celgene have been regarded as quirky and "out-of-synch" with the industry, but after yesterday's presentation investors are likely to consider them industry innovation leaders, at least in a specific set of technology and disease domains.

    Sentiment: Strong Buy

97.89-4.04(-3.96%)Feb 5 4:00 PMEST